GE HealthCare Technologies Inc. (NasdaqGS: GEHC)
Health Care · Health Care Equipment & Supplies · US
$74.82
+1.04% today · +2.3% 1Y
GE HealthCare Technologies Inc. (NasdaqGS: GEHC) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $33.80B and employs 54,000 people.
Over the last twelve months the share price has gained 2.3%, trading between 58.75 and 89.77.
Tweenvest scores GE HealthCare Technologies Inc. across four factors: quality 62/100, value 66/100, growth 19/100, dividend 41/100. Its strongest factor is value.
GEHC price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $33.80B
- Revenue (TTM)
- $21.27B
- P/E
- 17.24
- EPS
- 4.34
- Dividend yield
- 0.19%
- Beta (5Y)
- 0.82
- 52-week high
- $89.77
- 52-week low
- $58.75
- Avg volume (3M)
- —
- Shares outstanding
- 451.69M
- Employees
- 54,000
- Next earnings
- —
About GE HealthCare Technologies Inc.
GE HealthCare Technologies Inc. is a global medical technology company that creates, manufactures, and markets a diverse range of medical devices, services, and integrated digital solutions. These offerings are designed to assist in the diagnosis, treatment, and ongoing monitoring of patients. The company boasts an extensive international presence, serving markets across the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, and Hong Kong, among other regions. Its operations are structured across four primary business divisions: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging division specializes in advanced diagnostic imaging technologies, including systems for molecular imaging, Computed Tomography (CT) scans, Magnetic Resonance (MR) imaging, image-guided therapy, and X-ray, alongside specialized women's health products. The Ultrasound segment delivers a comprehensive suite of ultrasound solutions utilized for the screening, diagnosis, treatment, and monitoring of various diseases. These applications span radiology, primary care, women's health, cardiovascular diagnostics, point-of-care, and portable handheld devices, in addition to products supporting surgical visualization and guidance. The Patient Care Solutions segment is dedicated to providing essential medical devices, consumable products, services, and digital platforms. Its portfolio encompasses patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal-infant care products. The Pharmaceutical Diagnostics segment supplies specialized diagnostic agents to the radiology and nuclear medicine industries. These include contrast media pharmaceuticals, administered to patients prior to scans like CT, angiography, X-ray, and MR, to enhance the visibility of internal tissues and structures. It also offers molecular imaging agents, or radiopharmaceuticals – molecular tracers labeled with radioisotopes – injected into patients for advanced diagnostic imaging applications such as Single-Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), and specific ultrasound procedures. Established in 2022, GE HealthCare Technologies Inc. maintains its corporate headquarters in Chicago, Illinois.
- Founded
- 2022
- Listed since
- Dec 15, 2022
- Exchange
- Nasdaq Global Select
- Currency
- USD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Abbott LaboratoriesNYSE: ABT | $201.83B | $116.85 | +0.18% |
| Intuitive Surgical, Inc.NasdaqGS: ISRG | $133.83B | $381.93 | +0.82% |
| Stryker CorporationNYSE: SYK | $126.37B | $332.00 | +0.77% |
| Medtronic plcNYSE: MDT | $119.49B | $93.79 | +0.47% |
| EssilorLuxottica Société anonymeENXTPA: EL | $87.56B | €162.30 | -0.55% |
| Boston Scientific CorporationNYSE: BSX | $73.00B | $50.60 | +0.46% |
| HOYA CorporationTSE: 7741 | $52.38B | ¥24,895.00 | -1.37% |
| Becton, Dickinson and CompanyNYSE: BDX | $52.30B | $192.00 | +2.33% |
Figures last refreshed Aug 18, 2026.